Blood Cancer Journal (May 2023)
Correction: Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients
- Rodrigo Fonseca,
- Mariano Arribas,
- Julia E. Wiedmeier-Nutor,
- Yael N. Kusne,
- Miguel González Vélez,
- Heidi E. Kosiorek,
- Richard (Duke) J. Butterfield,
- Ilan R. Kirsch,
- Joseph R. Mikhael,
- A. Keith Stewart,
- Craig Reeder,
- Jeremy Larsen,
- P. Leif Bergsagel,
- Rafael Fonseca
Affiliations
- Rodrigo Fonseca
- Division of Hematology and Medical Oncology, Mayo Clinic
- Mariano Arribas
- Division of Hematology and Medical Oncology, Mayo Clinic
- Julia E. Wiedmeier-Nutor
- Division of Hematology and Medical Oncology, Mayo Clinic
- Yael N. Kusne
- Division of Hematology and Medical Oncology, Mayo Clinic
- Miguel González Vélez
- Dignity Health Cancer Institute
- Heidi E. Kosiorek
- Department of Health Sciences Research, Mayo Clinic
- Richard (Duke) J. Butterfield
- Department of Health Sciences Research, Mayo Clinic
- Ilan R. Kirsch
- Translational Medicine, Adaptive Biotechnologies
- Joseph R. Mikhael
- Translational Genomics Research Institute, City of Hope Cancer Center
- A. Keith Stewart
- Princess Margaret Cancer Centre, University Health Network
- Craig Reeder
- Division of Hematology and Medical Oncology, Mayo Clinic
- Jeremy Larsen
- Division of Hematology and Medical Oncology, Mayo Clinic
- P. Leif Bergsagel
- Division of Hematology and Medical Oncology, Mayo Clinic
- Rafael Fonseca
- Division of Hematology and Medical Oncology, Mayo Clinic
- DOI
- https://doi.org/10.1038/s41408-023-00856-0
- Journal volume & issue
-
Vol. 13,
no. 1
pp. 1 – 2
Abstract
No abstracts available.
